Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 27
1982 32
1983 35
1984 54
1985 43
1986 52
1987 48
1988 38
1989 49
1990 50
1991 49
1992 43
1993 47
1994 37
1995 46
1996 41
1997 42
1998 37
1999 35
2000 40
2001 72
2002 108
2003 173
2004 187
2005 292
2006 298
2007 306
2008 398
2009 639
2010 611
2011 894
2012 987
2013 650
2014 426
2015 354
2016 290
2017 348
2018 387
2019 338
2020 325
2021 382
2022 321
2023 329
2024 117

Text availability

Article attribute

Article type

Publication date

Search Results

6,865 results

Results by year

Filters applied: . Clear all
Page 1
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.
Gonzalez D, Gupta L, Murthy V, Gonzalez EB, Williamson KA, Makol A, Tan CL, Sulaiman FN, Shahril NS, Isa LM, Martín-Nares E, Aggarwal R. Gonzalez D, et al. Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4. Rheumatol Int. 2022. PMID: 35661906 Free PMC article. Review.
Recent updates in enthesitis-related arthritis.
Naveen R, Guleria S, Aggarwal A. Naveen R, et al. Rheumatol Int. 2023 Mar;43(3):409-420. doi: 10.1007/s00296-023-05274-w. Epub 2023 Jan 11. Rheumatol Int. 2023. PMID: 36629936 Review.
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
Nakayama Y, Watanabe R, Murakami K, Murata K, Tanaka M, Ito H, Yamamoto W, Ebina K, Hata K, Hiramatsu Y, Katayama M, Son Y, Amuro H, Akashi K, Onishi A, Hara R, Yamamoto K, Ohmura K, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Rheumatol Int. 2022 Jul;42(7):1227-1234. doi: 10.1007/s00296-021-05086-w. Epub 2022 Mar 10. Rheumatol Int. 2022. PMID: 35266034
Nanotechnology applications in rheumatology.
Nune A, Barman B, Sapkota HR, Ish P, Chelliah EG, Diwan M, Chiphang A, Iyengar KP. Nune A, et al. Rheumatol Int. 2022 Nov;42(11):1883-1891. doi: 10.1007/s00296-022-05141-0. Epub 2022 May 19. Rheumatol Int. 2022. PMID: 35587833 Review.
Long COVID in autoimmune rheumatic diseases.
Fedorchenko Y, Zimba O. Fedorchenko Y, et al. Rheumatol Int. 2023 Jul;43(7):1197-1207. doi: 10.1007/s00296-023-05319-0. Epub 2023 Mar 30. Rheumatol Int. 2023. PMID: 36995436 Free PMC article. Review.
Age-related immunosenescence in Behçet's disease.
Üsküdar Cansu D, Korkmaz C. Üsküdar Cansu D, et al. Rheumatol Int. 2022 Sep;42(9):1513-1522. doi: 10.1007/s00296-022-05144-x. Epub 2022 May 20. Rheumatol Int. 2022. PMID: 35593976 Review.
6,865 results